Navigation Links
IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead
Date:7/25/2008

lth Care Corporation. "Tierre's passion and dedication to her work are known to everyone who has ever worked with her professionally," said Will. "We offer Tierre and her family all best wishes as she pursues new challenges."

IPRO is a nationally-recognized, independent quality improvement and evaluation organization, holding major contracts with state and federal governments, as well as private-sector clients. A not-for-profit organization, IPRO has annual revenues of $50 million and 400 employees based primarily in Lake Success and Albany, New York. IPRO holds ISO 9001:2000 Certification and is an Empire State Advantage Silver Award Winner.

Visit IPRO's award-winning Web site at http://www.ipro.org.


'/>"/>
SOURCE IPRO
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service
2. Boston Scientific Welcomes Progress on Pain Care Legislation
3. Hamilton Medical, Inc. Welcomes New Vice President
4. Sinexus Welcomes New CEO and Completes Series B
5. Susan G. Komen for the Cure(R)s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors
6. Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines
7. Andre Agassi College Preparatory School Welcomes YoNaturals Healthy Vending Program
8. Stratos Product Development Welcomes Back John Havard as Vice President of Engineering
9. US Oncology Welcomes New Director of Federal Government Relations
10. HIDA Welcomes the Introduction of Pedigree Reform Legislation and Urges Congressional Support for H.R. 5839
11. Covenant House Welcomes His Holiness Pope Benedict XVI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Businesses of all sizes lookin...for the H1N1 pandemic have a new resource at their... (PRWEB) November 9, 2009 -- Human resource (HR) p...d response efforts for the H1N1 pandemic have a ne...nnesota’s Center for Infectious Disease Rese...
(Date:11/9/2009)... House Delivers on Election Promise. Now Is Time f...wire-USNewswire/ -- The following is a statement b...enerations of struggle and decades of delay, the U...t -- and, to pass historic reform legislation to a... access to high quality, affordable health care. T...
(Date:11/9/2009)...RIVERWOODS, Ill., Nov. 9 The House...ealth Care for America Act , which passed by a vot...tes several significant changes to the tax code an...ely to appear in any Senate version, requiring ext...H has issued a Special Tax Briefing on the tax...
(Date:11/9/2009)...WASHINGTON, Nov. 9 The Churchill...s Award For Leadership to J.W. "Bill" Marriott for...rough progressive free market practices and foster...e. Mr. Marriott will receive his award at a ceremo...ngton D.C. Four Seasons Hotel. ,, "This is a t...
(Date:11/9/2009)...in mice reports success with drugs that inhibit es...ews) -- Two drugs used to treat breast cancer and ...ccording to a new study. , The drugs also clear...and prevented the onset of cancer in mice with pre...vestrant and the breast cancer/osteoporosis drug r...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
... disease that can have Complication as its other n...could have, the dreaded would be the foot ulcer, a...n. For diabetics with this dreaded foot ulcer, ... healing of foot ulcers. People with diabetes m...
...are being developed on a daily basis. One of these...nt of those suffering from a degenerative eye cond...sels to grow underneath the retina and leak fluid,...of damaging the retinal tissue. This is a two-s...
...l companies hope to strike a pot of gold by making... war that is likely to escalate in coming days. ...panies to develop anti-AIDS drugs and market it in... entry of four more pharmaceutical companies inclu...
...ing the worst forms of nightmare over the past 3 w... but the threat of malaria . Malaria , not a ... tribal areas of Munger, 200 km (125 miles) southe...id the state's health minister Mr.Shakuni Choudhar...
... the recent issue of the American Journal of Epide...elp protect against a hip fracture. According to D...al, Glostrup, Denmark, and colleagues, when people... hip fractures. In the study, they found tha...
...ministration (FDA) at a conference in Washington, ...ts kind that directly removes the sign of a protei...eatment for chronic myelogenous leukemia (CML). ...rectly cause the disease. Gleevec, was discover...
Other Medicine News:
(Date:11/9/2009)...NWOOD, Ill., Nov. 9 Lan... personal and environmental radiation monitoring s...uisitions in accordance with its long-term strateg...he acquisitions of Global Physics Solutions, Inc. ...l Saxelby, President and CEO of Landauer. "These a...
(Date:11/9/2009)...DCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstCall/ -... today announced that it has extended the expirati...eviously announced "Modified Dutch Auction" tender...cash, up to $65,000,000 aggregate principal amount... 2.875% Senior Subordinated Convertible Notes due ...
(Date:11/9/2009)...KVILLE, Md., Nov. 9 OriGene Techno...chnology in Sweden has adopted its VERIFY Tagged A...Protein Atlas program. This program is funded by t... up to explore the human proteome systematically u...uality mono-specific antibodies in a high throughp...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 1Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 2Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 3Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 430th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 8Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 9
...euticals (Nasdaq: VIAP ), a biotechnology company...reatment of cardiovascular disease,announced today... (DSMB),for its VIA-2291 Phase 2 clinical trial pr...s current Phase 2 studies. The DSMB observed a,con...ecommended VIA,continue its ongoing trials as plan...
...cess to FOSRENOL(R) and Resources fo...PHIA, April 3, 2008 Shire Pharmaceuticals, the,gl...e launch of On Track,an innovative program designe...ens among chronic kidney disease (CKD) Stage 5 pat...hosphorus in the blood). In addition,to offering t...
Other Medicine Technology:VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 8
Nova Epi-fluorescence
...are the hallmark of these stereozoom fluorescent m...n mind. The top (incident) circular 9W fluorescent...inating shadows while remaining cool to the touch....e with 10x to 44x zoom magnification or high-power...
...vative and efficient inverted routine microscope. ...cility. Improved mechanics and increased stability...cular and TS100-F trinocular models. The TS100-F t...ts Nikon's FX-III series photomicrographic systems...
...system utilizes an evanescent wave to excite singl...e coverglass. Extendable "stratum structure". This...th TIRF and epi-fluorescence illumination systems,...ies. It also allows their dedicated filters to be ...
Medicine Products: